OIOtito Frances Iwuchukwu

Otito Frances Iwuchukwu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Otito Frances Iwuchukwu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communities

    by Clarissa J. Klein, Li Gong, Kelly E. Caudle, Hetanshi Naik, Philip E. Empey, James M. Hoffman, Steve Scherer, Otito F. Iwuchukwu, David Gregornik, Andrew A. Monte, et al.


  • Open Access

    Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy

    by Katherine M. Robinson, Seenae Eum, Zeruesenay Desta, Rachel F. Tyndale, Andrea Gaedigk, Richard C. Crist, Cyrine E. Haidar, Alan L. Myers, Caroline F. Samer, Andrew A. Somogyi, et al.

    Methadone is a mu (μ) opioid receptor agonist used clinically in adults and children to manage opioid use disorder, neonatal abstinence syndrome, and acute and chronic pain. It is typically marketed as a racemic mixture of R‐ and S‐enantiomers. R‐methadone has 30‐to 50‐fold higher analgesic potency than S‐methadone, and S‐methadone has a greater adverse effect (prolongation) on the cardiac QTc interval. Methadone undergoes stereoselective metabolism. CYP2B6 is the primary enzyme responsible for catalyzing the metabolism of both enantiomers to the inactive metabolites, S‐ and R‐2‐ethylidene‐1,5‐dimethyl‐3,3‐diphenylpyrrolidine (S‐ and R‐EDDP). Genetic variation in the CYP2B6 gene has been investigated in the context of implications for methadone pharmacokinetics, dose, and clinical outcomes. Most CYP2B6 variants result in diminished or loss of CYP2B6 enzyme activity, which can lead to higher plasma methadone concentrations (affecting S‐ more than R‐methadone). However, the data do not consistently indicate that CYP2B6‐based metabolic variability has a clinically significant effect on methadone dose, efficacy, or QTc prolongation. Expert analysis of the published literature does not support a change from standard methadone prescribing based on CYP2B6 genotype (updates at www.cpicpgx.org).


  • The DEI Pendulum: Despite Backlash, the Work Must Continue

    by Otito Frances Iwuchukwu, Amy Ritchie Johnson

    If a pendulum sways gently to the ticking of time, we would be hard pressed to describe the current zeitgeist around diversity, equity, and inclusion (DEI) initiatives as anything but gentle. The pendulum has swung so far in the opposite direction that it is hard to believe just 4 years ago, in 2020, we had most organizations affirming their commitment to the principles of DEI. The impetus for this article came from the work of a subgroup of the CSE DEIA (A is for accessibility) committee charged with reviewing materials posted on the CSE DEIA resource page,1 which was previously described in Science Editor. The page review, a common practice for web-based resources, yielded a discomfiting observation—some of the links either did not exist any longer, or were replaced with a general webpage that no longer referenced DEI. One major academic publisher had previously posted a statement entitled “Committed to Inclusion and Equity, We Stand in Solidarity with Black Communities – Because Black Lives Matter,” but now that link lands on a general main page. The question of why organizations and decision makers would make such an about-face on advancing the cause of DEI is a multidimensional one at best, with no easy answers. Because organizations exist within a system of rule of law, they follow the direction of legislation around what is possible with DEI efforts. And organizations in scholarly publishing are no different. Prior to the U.S. Supreme Court decision against affirmative action in June 2023, many states […]

  • Building Diversity, Equity, Inclusion, and Accessibility Capacity: Resources to Promote Best Practices Among Professionals in Scholarly Publishing

    by Jr Leonard Jack, Peter J Olson, Patricia K Baskin, Otito Frances Iwuchukwu

    The Council of Science Editors (CSE) is an international organization of more than 500 editorial professionals in the scientific, scientific publishing, and information science communities. The organization’s goal is to serve as an authoritative resource on current and emerging issues in the communication of scientific information.1 Similar to other scholarly publishing organizations, CSE continues to facilitate important conversations and training regarding why, how, and where principles of diversity, equity, inclusion, and accessibility (DEIA) should be integrated into scholarly publishing. With guidance from CSE members with expertise in DEIA in scholarly publishing, and the approval of CSE’s Board of Directors, the organization established the DEI Committee in 2021 (which was expanded to the DEIA Committee in 2023). The purpose of the DEIA Committee is “to support the organization in building capacity among its leadership, members, and the profession at large to deliver programmatic activities and training that integrate [DEIA] best practices in science editing, publication management, scholarly publishing and communication, member recruitment, participation, and engagement.”2 Since the committee’s inception, CSE has implemented and/or participated in 8 broad-ranging DEIA-related activities: 1) adding new content to CSE’s Recommendations for Promoting Integrity in Scientific Journal Publications3 related to DEIA best practices in scholarly publishing; 2) completing a DEIA sensitivity review of Scientific Style and Format,4 the CSE style manual, for its upcoming 9th edition, scheduled for publication in 2024; 3) a DEIA-related symposium to update members on CSE’s progress in achieving DEIA-related objectives and activities identified in CSE’s Strategic Plan2; 4) establishing a DEIA […]


  • CSE’s Diversity, Equity, and Inclusion (DEI) Committee: Celebrating Our First Year of Growth, Successes, and Future Direction

    by Leondard Jack, Otito Frances Iwuchukwu, Peter J Olson, Amy Ritchie Johnson, Patricia K Baskin, Mary K Billingsley, Jennifer Deyton

    Scholarly publishing organization leaders, journal editor and editorial teams, and authors recognize that advancing diversity, equity, and inclusion (DEI) best practices helps to enhance diversity across a variety of areas, including but not limited to, disciplinary, racial and ethnic, and linguistic and cultural diversity, and to promote the value and benefits gained from diversity of opinion, thought, and perspective.1,2 Recently, there have been important and long-needed discussions regarding why, how, and where principles of DEI should be integrated into scholarly publishing.1 In September 2021, the Council of Science Editors (CSE) Board of Directors (BOD) approved the formation of the CSE DEI Committee out of the existing DEI Task Force, formed the year before. The original task force, and later the committee, grew from the BOD’s commitment to establishing CSE as a leader in the field of scholarly publishing on integrating timely, effective, and responsive DEI principles in organizational culture and operations, as well as in educational opportunities for members. The purpose of the CSE DEI Committee is to support the organization in building capacity among its leadership, members, and the profession at large to deliver programmatic activities and training that integrate DEI best practices in science editing, publication management, scholarly publishing and communication, member recruitment, participation, and engagement. Since the BOD’s approval of the DEI Committee, the priority has been to recruit active members. The committee currently consists of nearly 20 members working in various capacities among organizations and journals in scholarly publishing. The committee spent time early on deciding […]


  • Diversity, Equity, and Inclusion (DEI) Task Force Update and Future Direction

    by Melissa B Schmidt, Otito Frances Iwuchukwu

    As members of CSE, you’ve undoubtedly seen, in some capacity, our mission statement: “To serve editorial professionals in the sciences by creating a supportive network for career development, providing educational opportunities, and developing resources for identifying and implementing high-quality editorial practices.” While there’s no explicit mention of equitable representation and access in that single phrase—with respect to either the data published by the journals we represent or to our profession itself—there is an allusion to it in the supportive network verbiage that CSE leadership has taken great care to formalize in recent years. In 2017, CSE became one of 10 founding organizations of the Coalition for Diversity and Inclusion in Scholarly Communications (C4DISC). The mission of C4DISC is to “work with organizations and individuals to build equity, inclusion, diversity, and accessibility in scholarly communications.” In 2019, the CSE Board of Directors ratified a code of conduct affirming the organization’s commitment to equal opportunities and treatment for all regardless of race, ethnicity, gender, sexual orientation, gender identity and expression, disability, religion, age, appearance, or political affiliation, as well as its commitment to maintaining an environment free of harassment, discrimination, and hostility. Further, consequent to the nationwide protests against systemic racism, the CSE Board agreed upon the need for further action within our organization and, on June 8, 2020, approved the formation of the Diversity, Equity, and Inclusion (DEI) Task Force. With this inaugural column from the DEI Taskforce, we intend to create a regular open channel of communication between the Task […]